Mitchell H. Rosner, MD, FACP

Mitchell H. Rosner, MD, FACP


Professor of Medicine

MD: Medical College of Georgia
Residency: University of Virginia
Fellowship: University of Virginia
Certification: Internal Medicine, Nephrology

434-243-6133 | Fax 434-924-5848 |

I am primarily interested in improving the care of patients with all forms of kidney disease from acute kidney failure to end-stage kidney disease. Along these lines, I have several clinics per week that focus on patients with all forms of kidney disease with a specific focus on those patients with polycystic kidney disease and glomerulonephritis. I have started the first regional clinic that specifically focuses on patients with polycystic kidney disease. This clinic also allows patients with polycystic kidney disease to enter into clinical trials investigating novel therapies for this disease. I also serve as Medical Director for the kidney center clinic and strive to give patients a patient-centered, compassionate experience in our multidisciplinary clinic. I also serve as Vice Chairman for Clinical Affairs for the Department of Medicine

My research interests include: treatment of polycystic kidney disease, management of disorders of sodium and water balance and new diagnostic tools and therapies for acute kidney injury. Clinical trials in these areas are open to selected patients.

My other interest is in education and I serve as the fellowship director for the Nephrology division as well as Associate Director for the Medicine Residency program. We have developed a top training program for the next generation of Nephrologists by providing comprehensive education in all areas of Nephrology. Furthermore, I serve on the Executive Council of the American Society of Nephrology Training Program Directors which aims to set training standards for Nephrologists. I also serve on a number of national committees devoted to educational aspects of medical training.

PubMed Search for articles by faculty member »

Campbell GA, Rosner MH. The agony of ecstasy: the renal effects of MDMA. Clin J Am Soc Nephrol. 2008;3:1852-1860.

Rosner MH. Exercise associated hyponatremia. Semin Nephrol. 2009;29:271-281.

Rosner MH. Hyponatremia in patients with central nervous system disorders. Int J Clin Pract. 2009;63:348-350.

Rosner MH. Exercise-associated hyponatremia. Physician Sports Med. 2008;36:55-62.

Bissram M, Scott FD, Liu L, Rosner MH. Risk factors for symptomatic hyponatremia: the role of pre-existing asymptomatic hyponatremia. Int Med J. 2007;37:149-155.

Jo SK, Rosner MH, Okusa MD. Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon. Clin J Am Soc Nephrol. 2007;2: 356-365.

Rosner MH. Measuring risk in end-stage renal disease: is N-terminal pro brain natriuretic peptide a useful marker? Kidney Int. 2007;71:481-483.

Rosner MH, Kirven J. Exercise-associated hyponatremia. Clin J Am Soc Nephrol. 2007;2:151-161.

Liu J, Kalantarinia K, Rosner MH. Management of lipid abnormalities associated with end-stage kidney disease. Semin Dial. 2006;19:391-401.

Rosner MH, Okusa, MD. Acute renal failure associated with cardiopulmonary bypass surgery. Clin J Amer Soc Nephrol. 2006;1:19-33.

Shear W, Rosner MH. Acute kidney dysfunction secondary to the abdominal compartment syndrome. J Nephrol. 2006;19:556-566.